Medtronic Sued by 1,000 Infuse Patients (MedPageToday)
Medtronic said about 1,000 people have sued the company over its bone morphogenetic protein-2 (BMP-2) product, Infuse, and that many more lawsuits may be coming.
In addition, several states now are looking into sales and marketing practices involving Infuse, which is used in spine surgery.
In a statement, company spokesperson Cindy Resman said the cases are in early procedural stages, and none have resulted in a finding of liability against Medtronic.
Some court rulings have led to dismissals and others have limited claims.
"Medtronic stan...
